Aids Vaccine Research Inst entered the industry of Noncommercial Research Organizations in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5419100, which describes it as a Noncommercial Research Organizations. For further clarification, the SIC classifies this business under the code 8733 and described it as a Noncommercial Research Organizations. The business provides service to the B2B market.
To acquire more information, please contact Arlene Ransinch by calling (518) 439-5379 during business hours. You can also write to the business’ Single Location at 34 Placid Lane, Glenmont, New York NY 12077. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Aids Vaccine Research Inst |
| Representative: | Arlene Ransinch |
| Place of Business: | 34 Placid Lane, Glenmont, NY 12077 |
| Contact Number: | (518) 439-5379 |
| Type of Service: | Noncommercial Research Organizations |
| SIC Number: | 8733 |
| NAICS Number: | 5419100 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2001 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Aids Vaccine Research Inst is a company operating from Albany, New York providing professional Noncommercial Research Organizations and relevant B2B variables. It was founded in 2001 and registered with the SIC code 8733 as Noncommercial Research Organizations, and with the NAICS code 5419100 as Noncommercial Research Organizations.
With a current employee count of 1 to 4, Aids Vaccine Research Inst has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Arlene Ransinch at (518) 439-5379 for related queries, or to locate its Single Location using the coordinates 42.589814,-73.803822.
The Single Location can also be found at the street address 34 Placid Lane in Glenmont, New York 12077 and can be engaged online through the company website at , the company Twitter , and Facebook page .